Revised Guidance Reflects Strong Confidence

Shares of Turning Point Brands are demonstrating remarkable upward momentum, fueled primarily by the explosive growth of its Modern Oral nicotine division. The company is solidifying its position as a dynamic competitor within a rapidly evolving market landscape.

Management has significantly raised its full-year outlook, demonstrating substantial confidence in the company’s ongoing performance. Turning Point Brands increased its projected EBITDA range to $110-114 million, up from the previous forecast of Read more...